Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Marico Ltd

MARICO
NSE
779.30
0.20%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Marico Ltd

MARICO
NSE
779.30
0.20%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,01,165Cr
Close
Close Price
779.30
Industry
Industry
FMCG - Personal Care
PE
Price To Earnings
58.86
PS
Price To Sales
7.78
Revenue
Revenue
13,008Cr
Rev Gr TTM
Revenue Growth TTM
25.33%
PAT Gr TTM
PAT Growth TTM
7.16%
Peer Comparison
How does MARICO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MARICO
VS

Quarterly Results

Upcoming Results on
5 May 2026
Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
2,2402,4772,4762,4222,2782,6432,6642,7942,7303,2593,4823,537
Growth YoY
Revenue Growth YoY%
3.7-3.2-0.8-1.91.76.77.615.419.823.330.726.6
Expenses
ExpensesCr
1,8471,9031,9791,9091,8362,0172,1422,2612,2722,6042,9222,945
Operating Profit
Operating ProfitCr
393574497513442626522533458655560592
OPM
OPM%
17.523.220.121.219.423.719.619.116.820.116.116.7
Other Income
Other IncomeCr
684638431537824247564939
Interest Expense
Interest ExpenseCr
171720191717111312101214
Depreciation
DepreciationCr
433639424141414452454750
PBT
PBTCr
401567476495399605552518441656550567
Tax
TaxCr
961311161097913111911296143118107
PAT
PATCr
305436360386320474433406345513432460
Growth YoY
PAT Growth YoY%
18.715.717.315.94.98.720.35.27.88.2-0.213.3
NPM
NPM%
13.617.614.515.914.117.916.314.512.615.712.413.0
EPS
EPS
2.33.32.73.02.53.63.33.12.63.93.23.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
5,7336,0175,9186,3227,3347,3158,0489,5129,7649,65310,83113,008
Growth
Revenue Growth%
5.0-1.66.816.0-0.310.018.22.6-1.112.220.1
Expenses
ExpensesCr
4,8634,9664,7595,1856,0085,8466,4577,8317,9547,6278,69210,743
Operating Profit
Operating ProfitCr
8701,0511,1591,1371,3261,4691,5911,6811,8102,0262,1392,265
OPM
OPM%
15.217.519.618.018.120.119.817.718.521.019.817.4
Other Income
Other IncomeCr
599396851029510598144142208191
Interest Expense
Interest ExpenseCr
232117164050343956735348
Depreciation
DepreciationCr
84959089131140139139155158178194
PBT
PBTCr
8221,0291,1491,1171,2571,3741,5231,6011,7431,9372,1162,214
Tax
TaxCr
237305338290126331324346421435458464
PAT
PATCr
5857238118271,1311,0431,1991,2551,3221,5021,6581,750
Growth
PAT Growth%
23.712.12.036.8-7.815.04.75.313.610.45.5
NPM
NPM%
10.212.013.713.115.414.314.913.213.515.615.313.4
EPS
EPS
4.55.56.26.38.67.99.19.510.111.512.613.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
65129129129129129129129129129129130
Reserves
ReservesCr
1,7601,9572,2572,4562,8732,9213,1513,2193,6703,7033,8453,922
Current Liabilities
Current LiabilitiesCr
1,1021,3141,2491,4581,7241,7532,0132,1532,4292,4442,4612,837
Non Current Liabilities
Non Current LiabilitiesCr
1903645681981812392285618081,6111,636
Total Liabilities
Total LiabilitiesCr
3,1303,3813,6334,0814,9094,9705,5105,7866,9467,4218,3388,679
Current Assets
Current AssetsCr
1,8282,1072,3902,7943,2003,1493,3363,5053,8204,0035,0835,393
Non Current Assets
Non Current AssetsCr
1,3021,2741,2431,2871,7091,8212,1742,2813,1263,4183,2553,286
Total Assets
Total AssetsCr
3,1303,3813,6334,0814,9094,9705,5105,7866,9467,4218,3388,679

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
6658186495161,0621,2142,0071,0161,4191,3871,363
Investing Cash Flow
Investing Cash FlowCr
-179-197-9255-334-39-938425-865176-621
Financing Cash Flow
Financing Cash FlowCr
-625-601-574-567-698-1,147-1,058-1,290-560-1,542-649
Net Cash Flow
Net Cash FlowCr
-14718-518-34516153-692193
Free Cash Flow
Free Cash FlowCr
6077315673949191,0341,8708841,2371,2341,202
CFO To PAT
CFO To PAT%
113.7113.080.062.493.9116.4167.481.0107.392.382.2
CFO To EBITDA
CFO To EBITDA%
76.477.856.045.480.182.6126.260.478.468.563.7

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
24,96431,28737,98542,09544,56735,48453,13965,11162,02964,30484,395
Price To Earnings
Price To Earnings
44.648.551.251.740.034.845.353.047.543.351.6
Price To Sales
Price To Sales
4.35.26.46.15.64.46.06.25.65.86.7
Price To Book
Price To Book
13.715.515.916.314.811.616.219.416.316.721.1
EV To EBITDA
EV To EBITDA
28.829.632.837.133.524.233.138.734.231.539.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.649.052.347.045.248.946.942.945.250.850.3
OPM
OPM%
15.217.519.618.018.120.119.817.718.521.019.8
NPM
NPM%
10.212.013.713.115.414.314.913.213.515.615.3
ROCE
ROCE%
39.146.944.439.138.742.141.142.940.846.147.9
ROE
ROE%
32.034.734.032.037.734.236.537.534.839.241.7
ROA
ROA%
18.721.422.320.323.021.021.821.719.020.219.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Executive Summary** Marico Limited continues to demonstrate resilient performance, strategic agility, and successful diversification, with strong growth across core and emerging businesses. In FY25, the company surpassed **₹10,000 crores in consolidated revenue**, driven by disciplined execution, robust brand equity, and effective portfolio expansion. Market leadership in core categories—especially coconut oil—remains unchallenged, while strategic bets in **Foods, Premium Personal Care (PPC), and Digital-First Brands** are reshaping the growth trajectory. Marico is evolving from a legacy FMCG player into a **profitable, digitally enabled consumer goods company**, balancing volume-led growth with premiumization and innovation. Key initiatives like **Project SETU, Sales 3.0**, and digital brand integration are driving distribution excellence, rural penetration, and urban channel expansion. --- ## **1. Market Leadership & Core Business Strength** Marico maintains **dominant market shares** across key product categories in India: - **63% in branded coconut oil** (Parachute remains category leader) - **41% in oats** - **29% in value-added hair oils (VAHO)** - **47% in leave-in conditioners** - **53% in male hair styling** Despite raw material inflation pressures—particularly in **copra** due to weather and speculation—Parachute demonstrated **pricing inelasticity and volume resilience**, growing 5.5–6.5% historically during 35% price hikes. The recent **12% decline in copra prices** and improved monsoon outlook are expected to support **volume recovery**, especially as smaller players retreat. --- ## **2. Strategic Diversification: New Growth Engines** Marico’s growth strategy is anchored on the **“4 Ds”**: **Diversification, Distribution, Digital, and Diversity**. The shift in domestic revenue mix reflects aggressive success in scaling newer businesses. ### **a. Foods Business** - Reached **₹900+ crores in FY25**, growing at a **33% YoY rate** (5x growth since FY20). - Key drivers: **Saffola Oats, Muesli, Honey, Soya Chunks, Plix, True Elements**. - Innovation focus: - _Saffola Masala Millets_, _Cuppa Oats_, _Munchiez (low-fat snacking)_. - Expansion into health snacking, plant-based protein, and breakfast cereals. - **Distribution expansion** into general trade (GT), chemists, and modern trade via Project SETU. - **Targets**: - **~8x FY20 revenue by FY27 (~₹1,800 crores)**. - **>25% CAGR** through innovation, GT penetration, and omnichannel sales. ### **b. Premium Personal Care (PPC)** - Grew at a **24% CAGR (FY21–FY25)**; PPPC revenue share in international business up from **20% to 29% (FY25)**. - Key focus: **shampoos, serums, skincare, baby care, male grooming**. - India PPC driven by **Livon (serums), Set Wet (EDPs), Puresense, and Herbs India** (MENA). - **International premiumization ongoing** in Bangladesh, Vietnam, and MENA. - **Targets**: - Sustain **25%+ CAGR**. - Maintain **double-digit constant currency growth** in international markets despite macro volatility. ### **c. Digital-First Brands** - Achieved **₹750 crores APR (Annualised Recurring Revenue, FY25)**. - Portfolio includes: - **Beardo** (male grooming – now **66% non-beard revenue**, near **double-digit EBITDA**). - **Plix** (nutraceuticals – reached **breakeven**, single-digit EBITDA). - **Just Herbs & True Elements** (near breakeven, targeting 20–25% growth). - **Integrated profit model**: Leveraging **Marico’s manufacturing, procurement, and media buying** for margin uplifts (e.g., **500–600 bps gross margin improvement for Beardo** via insourcing). - **Targets**: - Scale to **~2.5x FY24 APR by FY27 (~₹1,000–1,100 crores)**. - Achieve **blended double-digit EBITDA margin** by FY27. - **₹100 crore revenue opportunity** from **Kaya collaboration** (dermatologist-backed products). --- ## **3. Distribution & Sales Transformation** ### **Project SETU (Sales Expansion through Urban & Rural Reach)** - Launched in **April 2024**, expanded to **11 states**. - Aims to increase **direct distribution from 1M to 1.5M outlets by FY27**. - Cost-neutral, funded via **trade spend optimization** and efficiency gains. - Focus: **Rural GT expansion, specialty channels (chemists, bakeries), product assortment in urban outlets**. - Early results show improved **distributor ROI, GT channel recovery, and penetration of secondary brands**. ### **Sales 3.0 Framework** - Restructured sales from **4 divisions to 7 consumer-behavior-driven clusters**. - Enhances **micro-market decision-making**, powered by: - **Sales Control Tower**. - **EDGE (Every Day Great Execution)**. - **AI-powered product recommendation engine** (piloted). - Supports **focused strategies across GT, modern trade, e-commerce, and quick commerce**. ### **Quick Commerce & Omnichannel** - **Quick commerce contributes ~3%** of India business. - Brands like **Saffola Oats, Plix, Beardo, PureSense** are adapting packs for impulse purchase. - **ConCore platform (AI-powered consumer engagement tool)** launched with Salesforce to enhance support and personalization. --- ## **4. International Business: Geographic Diversification & Premiumization** - **~26% of group revenue**. - Reduced reliance on Bangladesh (from **51% in FY22 to ~42% in FY25**) via growth in **MENA, South Africa, and Vietnam**. - **Double-digit constant currency growth in FY25**, despite challenges. - Key growth drivers: - Bangladesh: expansion into **shampoos, baby care, skincare** (non-coconut oil now ~60% of business). - Vietnam: **female personal care (Lashe, Purity, Oliv), seasoning (Thuan Phat)**. - South Africa: **Isoplus (XTREME styling), healthcare products**. - MENA: **Herbs India, Parachute variants, Purité de Prôvence**. - Strategy: Replicate Bangladesh’s **distribution-led model**, invest in premiumization, and pursue **inorganic opportunities**. --- ## **5. Portfolio Optimization & Brand Strategy** - **SKU Rationalization** across brands to focus on **fewer, higher-potential products**. - **Shift away from low-margin segments** like Amla hair oils in favor of **higher-margin, mid-premium brands** (e.g., Parachute Advansed, Hair & Care). - **Avoided price wars**, instead focusing on **brand equity and share of voice**. - **Double-digit volume growth** reported in non-core VAHO brands like **Jasmine, Aloe, Ayurvedic, and Hair & Care**. --- ## **6. Innovation & R&D** - Operates **state-of-the-art Mumbai R&D center** with **134 experts** (108 in India). - Focus areas: **Hair biology, dermatology, functional nutrition, Ayurvedic science**. - Launched **over 15 new products in FY25**, including: - **Parachute Advansed variants** with keratin, biotin, vitamin E, aloe vera, and baby care range. - **Saffola Cold-Pressed Oils, Masala Millets, Muesli, Peanut Butter, Mayonnaise**. - **Plix digital-first campaigns (Build Your Own Box, #PlixWeightLossQuiz)**. - Collaborations with **Kaya Limited** to scale **efficacy-driven dermatology products** outside clinics. --- ### **Key Risks & Mitigation** - **Input Cost Volatility (e.g., copra)**: Countered through **pricing, inventory management, and cost efficiency**. - **Rural Demand Fluctuations**: Monitored via **Project SETU, rural investment**, and festive season momentum. - **International Macroeconomic Pressure**: Diversification, **pricing, and cost optimization** in key markets. - **Digital Competition**: Avoided cash burn model; focused on **profitable scalability via synergies**.